1. Home
  2. Analysis
  3. Profen
  4. Saccharomyces

Profen and Saccharomyces drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Profen and Saccharomyces. Common interactions include dehydration among females and blood creatine phosphokinase increased among males.

The phase IV clinical study analyzes what interactions people who take Profen and Saccharomyces have. It is created by eHealthMe based on reports of 33 people who take Profen and Saccharomyces from the FDA, and is updated regularly. You can use the study as a second opinion to make health care decisions.

Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.

On Nov, 30, 2022

33 people who take Profen and Saccharomyces together, and have interactions are studied.

What is Profen?

Profen has active ingredients of ibuprofen. It is often used in pain. eHealthMe is studying from 210,455 Profen users for its effectiveness, alternative drugs and more.

What is Saccharomyces?

Saccharomyces has active ingredients of saccharomyces boulardii. eHealthMe is studying from 897 Saccharomyces users for its effectiveness, alternative drugs and more.

Number of Profen and Saccharomyces reports submitted per year:

Profen and Saccharomyces drug interactions.

Common Profen and Saccharomyces drug interactions by gender *:

female:

  1. Dehydration
  2. Dementia
  3. Device related infection
  4. Dizziness
  5. Drug withdrawal syndrome
  6. Duodenitis
  7. Enterococcal infection
  8. Fall
  9. Fear
  10. Fluid retention

male:

  1. Blood creatine phosphokinase increased
  2. Infusion related reaction
  3. Flank pain
  4. Hyperkalaemia
  5. Hypertension
  6. Malignant neoplasm progression
  7. Mental status changes
  8. Metastases to liver
  9. Peripheral swelling
  10. Pleural effusion

Common Profen and Saccharomyces drug interactions by age *:

0-1:

n/a

2-9:

n/a

10-19:

  1. Alanine aminotransferase increased
  2. Aspartate aminotransferase increased
  3. Colitis
  4. Drug-induced liver injury
  5. Ileitis
  6. Colitis ulcerative
  7. Drug ineffective
  8. Fall
  9. Renal cancer

20-29:

  1. Paraesthesia
  2. Abdominal pain upper
  3. Anxiety
  4. Autoimmune disorder
  5. Diarrhoea
  6. Fatigue
  7. Fear
  8. Headache
  9. Hyperhidrosis
  10. Injury

30-39:

  1. Necrosis ischaemic
  2. Pneumonia streptococcal
  3. Septic shock
  4. Urinary tract infection
  5. Beta haemolytic streptococcal infection
  6. Loss of consciousness

40-49:

  1. Asthenia
  2. Contusion
  3. Heart rate decreased
  4. Heparin-induced thrombocytopenia
  5. Hepatic failure
  6. Hypersensitivity
  7. Lethargy
  8. Muscle disorder
  9. Renal failure
  10. Adverse event

50-59:

  1. Blood creatine phosphokinase increased
  2. Infusion related reaction
  3. Ligament rupture
  4. Arrhythmia
  5. Abdominal distension
  6. Abdominal pain
  7. Diarrhoea
  8. Gastritis

60+:

  1. Hypertension
  2. Acute respiratory failure
  3. Hyperlipidaemia
  4. Hyperosmolar state
  5. Hypotension
  6. Ileus paralytic
  7. Metabolic acidosis
  8. Peptic ulcer
  9. Pleural effusion
  10. Renal failure acute

Common conditions people have *:

  1. Insomnia (sleeplessness): 13 people, 39.39%
  2. Malignant Melanoma (skin cancer rises from melancytes): 4 people, 12.12%
  3. Pneumonia: 4 people, 12.12%
  4. Blood Uric Acid Increased: 3 people, 9.09%
  5. Nasopharyngitis (inflammation of the nasopharynx): 3 people, 9.09%
  6. Joint Pain: 3 people, 9.09%
  7. Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 3 people, 9.09%
  8. Musculoskeletal Pain (pain affects the bones, muscles, ligaments, tendons, and nerves): 3 people, 9.09%
  9. Thrombosis (formation of a blood clot inside a blood vessel): 3 people, 9.09%
  10. Gastric Ulcer (stomach ulcer): 3 people, 9.09%

* Approximation only. Some reports may have incomplete information.

Do you take Profen and Saccharomyces?

Personalize this study to your gender and age

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.

Related publications that referenced our studies

Related studies

Alternative drugs to, pros and cons of the 2 drugs:

Browse all drug interactions of Profen and Saccharomyces:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Common Profen side effects:

Browse all side effects of Profen:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Common Saccharomyces side effects:

Browse all side effects of Saccharomyces:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Common Profen interactions:

Browse all interactions between Profen and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Common Saccharomyces interactions:

Browse all interactions between Saccharomyces and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on ibuprofen and saccharomyces boulardii (the active ingredients of Profen and Saccharomyces, respectively), and Profen and Saccharomyces (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study. Patients in the study may take other drugs besides Profen and Saccharomyces.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe:

© 2023 eHealthMe.com. All rights reserved. Use of this site constitutes acceptance of eHealthMe.com's terms of service and privacy policy.